Atlas Trials

ZS Ph2/3 Dose-response Study in Japan

Clinical trial NCT03127644 · COMPLETED

Trial details

NCT number
NCT03127644
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hyperkalemia
Start date
2017-06-14
Primary completion
2018-02-23
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.